Terry_Tey personal page - To The Moon

Terry_Tey

No personal profile

7Follow

1Followers

0Topic

0Badge

2021-12-21

huhuhuh

After-Hours Stock Movers: Micron,Nike,Aldeyra Therapeutics and more

2021-08-09

…..

Sorry, the original content has been removed

2021-07-08

o

A So-Called “Meme Stock” That’s Actually Worth the Hype

2021-07-08

???

COVID-19 vaccine vial maker Stevanato eyes $7 bln valuation in U.S. IPO

2021-04-27

....

Google Stock Momentum Will Be Tested In First Quarter Earnings Report

2021-04-27

?

Sorry, the original content has been removed

2021-04-09

$Luokung Technology Corp(LKCO)$.....

2021-04-01

?

UOB CEO's pay falls 8.8% to $9.8m in 2020

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3569246059375185","uuid":"3569246059375185","gmtCreate":1606153100585,"gmtModify":1606153100585,"name":"Terry_Tey","pinyin":"terryteyterrytey","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":7,"tweetSize":8,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.08.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.02.11","exceedPercentage":"60.96%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"80.74%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.08.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},"individualDisplayBadges":null,"crmLevel":5,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":9000155100,"gmtCreate":1640046821090,"gmtModify":1676533499180,"author":{"id":"3569246059375185","authorId":"3569246059375185","name":"Terry_Tey","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569246059375185","authorIdStr":"3569246059375185"},"themes":[],"htmlText":"huhuhuh","listText":"huhuhuh","text":"huhuhuh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9000155100","repostId":"1102941409","repostType":4,"repost":{"id":"1102941409","pubTimestamp":1640044036,"share":"https://ttm.financial/m/news/1102941409?lang=&edition=fundamental","pubTime":"2021-12-21 07:47","market":"us","language":"en","title":"After-Hours Stock Movers: Micron,Nike,Aldeyra Therapeutics and more","url":"https://stock-news.laohu8.com/highlight/detail?id=1102941409","media":"StreetInsider","summary":"Micron Technology +6.6%; reported Q1 EPS of $2.16, $0.05 better than the analyst estimate of $2.11. Revenue for the quarter came in at $7.69 billion versus the consensus estimate of $7.67 billion. GUIDANCE: Micron Technology sees Q2 2022 EPS of $1.85-$2.05, versus the consensus of $1.86. Micron Technology sees Q2 2022 revenue of $7.3-7.7 billion, versus the consensus of $7.27 billion.Nike +3.4%; reported Q2 EPS of $0.83, $0.20 better than the analyst estimate of $0.63. Revenue for the quarter ca","content":"<p>After-Hours Stock Movers:</p>\n<p>Micron Technology (NASDAQ:MU)<b>+6.6%</b>; reported Q1 EPS of $2.16, $0.05 better than the analyst estimate of $2.11. Revenue for the quarter came in at $7.69 billion versus the consensus estimate of $7.67 billion. GUIDANCE: Micron Technology sees Q2 2022 EPS of $1.85-$2.05, versus the consensus of $1.86. Micron Technology sees Q2 2022 revenue of $7.3-7.7 billion, versus the consensus of $7.27 billion.</p>\n<p>Nike (NYSE:NKE)<b>+3.4%</b>; reported Q2 EPS of $0.83, $0.20 better than the analyst estimate of $0.63. Revenue for the quarter came in at $11.4 billion versus the consensus estimate of $11.25 billion.</p>\n<p>Aldeyra Therapeutics (NASDAQ:ALDX)<b>-39%</b>; announced top-line results from the Phase 3 TRANQUILITY Trial of 0.25% reproxalap ophthalmic solution (reproxalap), an investigational product candidate for the treatment of dry eye disease. Although the primary endpoint of ocular redness was not met in TRANQUILITY, statistical significance (p=0.0001) was achieved for the dry eye disease sign of Schirmer test, a secondary endpoint. Statistical significance (p&lt;0.0001) was also achieved for the post-hoc assessment of Schirmer test responders of ≥10 mm.</p>\n<p>Society Pass (NASDAQ: SOPA)<b>-11.8%</b>; Climbed 240% intraday.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Micron,Nike,Aldeyra Therapeutics and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Micron,Nike,Aldeyra Therapeutics and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-21 07:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1220%3A+%28MU%29+%28NKE%29+%28ALDX%29+%28SOPA%29/19375559.html><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nMicron Technology (NASDAQ:MU)+6.6%; reported Q1 EPS of $2.16, $0.05 better than the analyst estimate of $2.11. Revenue for the quarter came in at $7.69 billion versus the ...</p>\n\n<a href=\"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1220%3A+%28MU%29+%28NKE%29+%28ALDX%29+%28SOPA%29/19375559.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NKE":"耐克","ALDX":"Aldeyra Therapeutics Inc","SOPA":"Society Pass Inc","MU":"美光科技"},"source_url":"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1220%3A+%28MU%29+%28NKE%29+%28ALDX%29+%28SOPA%29/19375559.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102941409","content_text":"After-Hours Stock Movers:\nMicron Technology (NASDAQ:MU)+6.6%; reported Q1 EPS of $2.16, $0.05 better than the analyst estimate of $2.11. Revenue for the quarter came in at $7.69 billion versus the consensus estimate of $7.67 billion. GUIDANCE: Micron Technology sees Q2 2022 EPS of $1.85-$2.05, versus the consensus of $1.86. Micron Technology sees Q2 2022 revenue of $7.3-7.7 billion, versus the consensus of $7.27 billion.\nNike (NYSE:NKE)+3.4%; reported Q2 EPS of $0.83, $0.20 better than the analyst estimate of $0.63. Revenue for the quarter came in at $11.4 billion versus the consensus estimate of $11.25 billion.\nAldeyra Therapeutics (NASDAQ:ALDX)-39%; announced top-line results from the Phase 3 TRANQUILITY Trial of 0.25% reproxalap ophthalmic solution (reproxalap), an investigational product candidate for the treatment of dry eye disease. Although the primary endpoint of ocular redness was not met in TRANQUILITY, statistical significance (p=0.0001) was achieved for the dry eye disease sign of Schirmer test, a secondary endpoint. Statistical significance (p<0.0001) was also achieved for the post-hoc assessment of Schirmer test responders of ≥10 mm.\nSociety Pass (NASDAQ: SOPA)-11.8%; Climbed 240% intraday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":549,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":898291468,"gmtCreate":1628498436454,"gmtModify":1703507100917,"author":{"id":"3569246059375185","authorId":"3569246059375185","name":"Terry_Tey","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569246059375185","authorIdStr":"3569246059375185"},"themes":[],"htmlText":"…..","listText":"…..","text":"…..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/898291468","repostId":"1190142555","repostType":4,"isVote":1,"tweetType":1,"viewCount":344,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":140729786,"gmtCreate":1625674755045,"gmtModify":1703746289855,"author":{"id":"3569246059375185","authorId":"3569246059375185","name":"Terry_Tey","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569246059375185","authorIdStr":"3569246059375185"},"themes":[],"htmlText":"o","listText":"o","text":"o","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/140729786","repostId":"1133802649","repostType":4,"repost":{"id":"1133802649","pubTimestamp":1625667870,"share":"https://ttm.financial/m/news/1133802649?lang=&edition=fundamental","pubTime":"2021-07-07 22:24","market":"us","language":"en","title":"A So-Called “Meme Stock” That’s Actually Worth the Hype","url":"https://stock-news.laohu8.com/highlight/detail?id=1133802649","media":"investorplace","summary":"Don’t throw the baby out with the bath water.\nWe’ve all heard the saying several times, and we’ve al","content":"<p>Don’t throw the&nbsp;<b><i>baby</i></b>&nbsp;out with the&nbsp;<b><i>bath water</i></b>.</p>\n<p>We’ve all heard the saying several times, and we’ve all heard it applied to many different situations in many different industries. But I think that saying is perhaps most appropriate when talking about so-called “<b>meme stocks</b>” on Wall Street.</p>\n<p>Quick refresher: Meme stocks are the new term given to certain individual stocks that retail traders target via social media threads to collectively pour their money into and cause an epic rally in the share price in a short amount of time.</p>\n<p>See: GameStop, AMC, Koss, etc.</p>\n<p>Now, to be clear, most meme stocks are – from a fundamental value perspective –&nbsp;<u>complete garbage</u>. I mean… GameStop, AMC, and Koss all do have an opportunity to turn their businesses around, but realistically speaking, they still operate antiquated business models that are burning tons of cash and are being disrupted by tech startups.</p>\n<p>That’s just the facts.</p>\n<p>Having said that,<b>&nbsp;not all meme stocks are fundamentally broken</b>. Too many investors make the mistake of throwing the baby out with the bath water here. They see GameStop, AMC, and Koss, and immediately assume all meme stocks are equally fundamentally weak.</p>\n<p>But they aren’t…</p>\n<p>Take&nbsp;<b>Virgin Galactic</b>, for example. That’s a meme stock, but it’s also a space tourism pioneer doing some really amazing things that will one day create the basis for in-space “Disneyland rides.”</p>\n<p>We told you about Virgin Galactic back in late June when the stock was trading for just $15. It nearly touched $60 just last week.</p>\n<p>Another example:&nbsp;<b>Clean Energy Fuels</b>. It’s a meme stock. The company is also at the epicenter of the totally underrated renewable natural gas megatrend and could one day be an enormous clean fuel supplier for cross-country trucks.</p>\n<p>We told you about Clean Energy Fuels in December. It’s since soared as much as 210% for readers.</p>\n<p>Get the point?</p>\n<p>Some meme stocks are fundamentally broken. Others are not. There’s a lot of money to be made by knowing the difference and buying the meme stocks that, when all the hype fades, will continue to shine.</p>\n<p>Today, we are going to tell you about one such meme stock.</p>\n<p>Recently, it’s been one of the most popular meme stocks. But being a “meme” is perhaps the least interesting thing about this company, because at its core, this business is improving access to – and affordability of – healthcare for tens of millions of Americans using advanced machine learning algorithms. It’s a genius business and, when all the hype fades, this stock will keep soaring.</p>\n<p><b>A New &amp; Improved Way to Do Medicare</b></p>\n<p>There is something terribly wrong with&nbsp;<b>healthcare</b>&nbsp;in this country.</p>\n<p>Just look at the numbers…</p>\n<p>We spend&nbsp;<b><i>more money</i></b>&nbsp;than every other country in the world on healthcare. It’s not even close (about $11,000 per capita versus $5,000 to $7,000 for most of Europe). Yet, we have&nbsp;<b><i>lower life expectancy</i></b>&nbsp;(78.7 years versus 80.7 years for some European countries),&nbsp;<b><i>more health problems</i></b>&nbsp;(28% of Americans have 2 or more chronic conditions), and&nbsp;<b><i>a ton of unhappy customers</i></b>&nbsp;(81% of U.S. consumers are dissatisfied with their healthcare experience).</p>\n<p>This needs to change. U.S. healthcare has to get cheaper and deliver better outcomes for a better future.</p>\n<p><b>Clover</b>&nbsp;(NASDAQ:<b>CLOV</b>) could be the company that pioneers this long overdue healthcare revolution.</p>\n<p>The core idea of Clover is very simple: In short,&nbsp;<u>replace the healthcare administration system with artificial intelligence (AI)</u>.</p>\n<p>To do so, Clover has consumers fill out simple surveys to collect a bunch of healthcare data, which it then throws into a machine learning model called “Clover Assistant” and outputs a bunch of personalized care routines so that doctors can make informed decisions about their patients.</p>\n<p>This process makes healthcare&nbsp;<b><i>cheaper</i></b>, because it eliminates all the profit-takers in the healthcare administration supply chain and replaces them with a scalable AI technology.</p>\n<p>It also&nbsp;<b><i>improves patient outcomes</i></b>, because it leans into the power of AI to make smarter, data-driven healthcare decisions personalized at the individual level.</p>\n<p>While that idea sounds simple, the execution of it is very difficult due to the enormity of healthcare data in the world and the difficulty in processing all that data to glean valuable insights…&nbsp;<u>but that’s where Clover shines</u>.</p>\n<p>Clover has developed the industry’s best machine learning models for healthcare, which is why folks on Clover healthcare plans visit their doctors ~20% less and spend ~20% less on said visits.</p>\n<p>It’s cheaper, better healthcare.</p>\n<p>Clover is first applying this novel AI-powered healthcare administration process to older folks, for which it has developed a Clover-powered Medicare Advantage plan that is the fastest-growing Medicare Advantage plan in America… by a long shot.</p>\n<p>But that’s just the start. Clover Assistant is scalable. It can be applied across&nbsp;<b>every facet of the healthcare industry</b>&nbsp;where there are inefficiencies in administration. And, to that extent, this is a company in the early stages of redefining a $3.65 TRILLION market.</p>\n<p>Yet, Clover is worth just about $5 billion today…</p>\n<p>Obviously, the long-term upside potential here is huge. To be sure, the stock has gone parabolic recently as retail traders have targeted the name. This won’t last. The hype will fade. And the stock will fall.</p>\n<p>But… when it does… that may be an&nbsp;<b>awesome time to buy the dip</b>&nbsp;for the long haul, because underneath the meme mania, there’s an AI-powered healthcare technology company here that’s doing some really exciting things.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A So-Called “Meme Stock” That’s Actually Worth the Hype</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA So-Called “Meme Stock” That’s Actually Worth the Hype\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-07 22:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/hypergrowthinvesting/2021/07/a-so-called-meme-stock-thats-actually-worth-the-hype/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Don’t throw the baby out with the bath water.\nWe’ve all heard the saying several times, and we’ve all heard it applied to many different situations in many different industries. But I think that ...</p>\n\n<a href=\"https://investorplace.com/hypergrowthinvesting/2021/07/a-so-called-meme-stock-thats-actually-worth-the-hype/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CLNE":"Clean Energy Fuels Corp","AMC":"AMC院线","CLOV":"Clover Health Corp","GME":"游戏驿站","SPCE":"维珍银河"},"source_url":"https://investorplace.com/hypergrowthinvesting/2021/07/a-so-called-meme-stock-thats-actually-worth-the-hype/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1133802649","content_text":"Don’t throw the baby out with the bath water.\nWe’ve all heard the saying several times, and we’ve all heard it applied to many different situations in many different industries. But I think that saying is perhaps most appropriate when talking about so-called “meme stocks” on Wall Street.\nQuick refresher: Meme stocks are the new term given to certain individual stocks that retail traders target via social media threads to collectively pour their money into and cause an epic rally in the share price in a short amount of time.\nSee: GameStop, AMC, Koss, etc.\nNow, to be clear, most meme stocks are – from a fundamental value perspective – complete garbage. I mean… GameStop, AMC, and Koss all do have an opportunity to turn their businesses around, but realistically speaking, they still operate antiquated business models that are burning tons of cash and are being disrupted by tech startups.\nThat’s just the facts.\nHaving said that, not all meme stocks are fundamentally broken. Too many investors make the mistake of throwing the baby out with the bath water here. They see GameStop, AMC, and Koss, and immediately assume all meme stocks are equally fundamentally weak.\nBut they aren’t…\nTake Virgin Galactic, for example. That’s a meme stock, but it’s also a space tourism pioneer doing some really amazing things that will one day create the basis for in-space “Disneyland rides.”\nWe told you about Virgin Galactic back in late June when the stock was trading for just $15. It nearly touched $60 just last week.\nAnother example: Clean Energy Fuels. It’s a meme stock. The company is also at the epicenter of the totally underrated renewable natural gas megatrend and could one day be an enormous clean fuel supplier for cross-country trucks.\nWe told you about Clean Energy Fuels in December. It’s since soared as much as 210% for readers.\nGet the point?\nSome meme stocks are fundamentally broken. Others are not. There’s a lot of money to be made by knowing the difference and buying the meme stocks that, when all the hype fades, will continue to shine.\nToday, we are going to tell you about one such meme stock.\nRecently, it’s been one of the most popular meme stocks. But being a “meme” is perhaps the least interesting thing about this company, because at its core, this business is improving access to – and affordability of – healthcare for tens of millions of Americans using advanced machine learning algorithms. It’s a genius business and, when all the hype fades, this stock will keep soaring.\nA New & Improved Way to Do Medicare\nThere is something terribly wrong with healthcare in this country.\nJust look at the numbers…\nWe spend more money than every other country in the world on healthcare. It’s not even close (about $11,000 per capita versus $5,000 to $7,000 for most of Europe). Yet, we have lower life expectancy (78.7 years versus 80.7 years for some European countries), more health problems (28% of Americans have 2 or more chronic conditions), and a ton of unhappy customers (81% of U.S. consumers are dissatisfied with their healthcare experience).\nThis needs to change. U.S. healthcare has to get cheaper and deliver better outcomes for a better future.\nClover (NASDAQ:CLOV) could be the company that pioneers this long overdue healthcare revolution.\nThe core idea of Clover is very simple: In short, replace the healthcare administration system with artificial intelligence (AI).\nTo do so, Clover has consumers fill out simple surveys to collect a bunch of healthcare data, which it then throws into a machine learning model called “Clover Assistant” and outputs a bunch of personalized care routines so that doctors can make informed decisions about their patients.\nThis process makes healthcare cheaper, because it eliminates all the profit-takers in the healthcare administration supply chain and replaces them with a scalable AI technology.\nIt also improves patient outcomes, because it leans into the power of AI to make smarter, data-driven healthcare decisions personalized at the individual level.\nWhile that idea sounds simple, the execution of it is very difficult due to the enormity of healthcare data in the world and the difficulty in processing all that data to glean valuable insights… but that’s where Clover shines.\nClover has developed the industry’s best machine learning models for healthcare, which is why folks on Clover healthcare plans visit their doctors ~20% less and spend ~20% less on said visits.\nIt’s cheaper, better healthcare.\nClover is first applying this novel AI-powered healthcare administration process to older folks, for which it has developed a Clover-powered Medicare Advantage plan that is the fastest-growing Medicare Advantage plan in America… by a long shot.\nBut that’s just the start. Clover Assistant is scalable. It can be applied across every facet of the healthcare industry where there are inefficiencies in administration. And, to that extent, this is a company in the early stages of redefining a $3.65 TRILLION market.\nYet, Clover is worth just about $5 billion today…\nObviously, the long-term upside potential here is huge. To be sure, the stock has gone parabolic recently as retail traders have targeted the name. This won’t last. The hype will fade. And the stock will fall.\nBut… when it does… that may be an awesome time to buy the dip for the long haul, because underneath the meme mania, there’s an AI-powered healthcare technology company here that’s doing some really exciting things.","news_type":1},"isVote":1,"tweetType":1,"viewCount":151,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":140720450,"gmtCreate":1625674685370,"gmtModify":1703746287881,"author":{"id":"3569246059375185","authorId":"3569246059375185","name":"Terry_Tey","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569246059375185","authorIdStr":"3569246059375185"},"themes":[],"htmlText":"???","listText":"???","text":"???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/140720450","repostId":"1128740137","repostType":4,"repost":{"id":"1128740137","pubTimestamp":1625668639,"share":"https://ttm.financial/m/news/1128740137?lang=&edition=fundamental","pubTime":"2021-07-07 22:37","market":"us","language":"en","title":"COVID-19 vaccine vial maker Stevanato eyes $7 bln valuation in U.S. IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=1128740137","media":"Reuters","summary":"July 7 (Reuters) - Italy's Stevanato Group S.p.A., a maker of glass vials for COVID-19 vaccine and o","content":"<p>July 7 (Reuters) - Italy's Stevanato Group S.p.A., a maker of glass vials for COVID-19 vaccine and other healthcare products, said on Wednesday it was seeking a valuation of over $7 billion in its U.S. initial public offering (IPO).</p>\n<p>Founded by billionaire Sergio Stevanato, the company said in its filing that a total of 40 million shares would be offered for sale priced between $21 and $24 each. The IPO would raise $960 million at the top end of that range.</p>\n<p>About 30% of those shares will be offered by the Stevenato family holding, an existing investor. The proceeds from those shares will not go to the company.</p>\n<p>Padua-based Stevanato Group started in 1949 as Soffieria Stella, a specialty glass manufacturer that was the precursor to the medical packaging company.</p>\n<p>The company started its international expansion in 2015 after the purchase of a primary packaging company in Slovakia.</p>\n<p>Stevanato, whose IPO plans were reported by Reuters in February, will list on the New York Stock Exchange under the symbol \"STVN\".</p>\n<p>Morgan Stanley, BofA Securities and Jefferies are the lead underwriters for the offering.</p>","source":"lsy1601381805984","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>COVID-19 vaccine vial maker Stevanato eyes $7 bln valuation in U.S. IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCOVID-19 vaccine vial maker Stevanato eyes $7 bln valuation in U.S. IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-07 22:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/business/healthcare-pharmaceuticals/stevanato-group-maker-covid-19-vaccine-vials-eyes-7-bln-valuation-us-ipo-2021-07-07/><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>July 7 (Reuters) - Italy's Stevanato Group S.p.A., a maker of glass vials for COVID-19 vaccine and other healthcare products, said on Wednesday it was seeking a valuation of over $7 billion in its U.S...</p>\n\n<a href=\"https://www.reuters.com/business/healthcare-pharmaceuticals/stevanato-group-maker-covid-19-vaccine-vials-eyes-7-bln-valuation-us-ipo-2021-07-07/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite"},"source_url":"https://www.reuters.com/business/healthcare-pharmaceuticals/stevanato-group-maker-covid-19-vaccine-vials-eyes-7-bln-valuation-us-ipo-2021-07-07/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1128740137","content_text":"July 7 (Reuters) - Italy's Stevanato Group S.p.A., a maker of glass vials for COVID-19 vaccine and other healthcare products, said on Wednesday it was seeking a valuation of over $7 billion in its U.S. initial public offering (IPO).\nFounded by billionaire Sergio Stevanato, the company said in its filing that a total of 40 million shares would be offered for sale priced between $21 and $24 each. The IPO would raise $960 million at the top end of that range.\nAbout 30% of those shares will be offered by the Stevenato family holding, an existing investor. The proceeds from those shares will not go to the company.\nPadua-based Stevanato Group started in 1949 as Soffieria Stella, a specialty glass manufacturer that was the precursor to the medical packaging company.\nThe company started its international expansion in 2015 after the purchase of a primary packaging company in Slovakia.\nStevanato, whose IPO plans were reported by Reuters in February, will list on the New York Stock Exchange under the symbol \"STVN\".\nMorgan Stanley, BofA Securities and Jefferies are the lead underwriters for the offering.","news_type":1},"isVote":1,"tweetType":1,"viewCount":459,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":377120005,"gmtCreate":1619507252007,"gmtModify":1704725094365,"author":{"id":"3569246059375185","authorId":"3569246059375185","name":"Terry_Tey","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569246059375185","authorIdStr":"3569246059375185"},"themes":[],"htmlText":"....","listText":"....","text":"....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/377120005","repostId":"1123330430","repostType":4,"repost":{"id":"1123330430","weMediaInfo":{"introduction":"The leading daily newsletter for the latest financial and business news. 33Yrs Helping Stock Investors with Investing Insights, Tools, News & More.","home_visible":0,"media_name":"Investors","id":"1085713068","head_image":"https://static.tigerbbs.com/608dd68a89ed486e18f64efe3136266c"},"pubTimestamp":1619506089,"share":"https://ttm.financial/m/news/1123330430?lang=&edition=fundamental","pubTime":"2021-04-27 14:48","market":"us","language":"en","title":"Google Stock Momentum Will Be Tested In First Quarter Earnings Report","url":"https://stock-news.laohu8.com/highlight/detail?id=1123330430","media":"Investors","summary":"Shares in Google-parentAlphabet(GOOGL) have been on a roll since it reported December-quarter earnin","content":"<p>Shares in Google-parent<b>Alphabet</b>(GOOGL) have been on a roll since it reported December-quarter earnings. But it may be hard for Google stock to deliver an encore performance with first-quarter results.</p>\n<p>\"We think Google faces a higher bar this quarter than the past few as expectations for a strong search and brand advertising recovery are anticipated,\" BMO Capital Markets analyst Daniel Salmon said in a report to clients.</p>\n<p>Google stock rose 0.4% to close at 2,309.93 on thestock market today.</p>\n<p>Google stock has advanced nearly 20% since it reported fourth-quarter earnings on Feb. 2. Google earnings for the first quarter are due after the market close on Tuesday.</p>\n<p>For the March quarter, analysts estimate adjusted profit of $15.66 per share, up 58% from $9.87 per share a year earlier. Google gross revenue, excluding traffic acquisition costs, will grow 25% to $51.53 billion, analysts estimate.</p>\n<p>Net revenue will come in at $42.36 billion, according to views. In the Google earnings report, analysts estimate EBITDA — earnings before interest, taxes, depreciation and amortization — of $18.84 billion.</p>\n<p>Google Stock: Rising Cloud Computing Investments</p>\n<p>At Bank of America, analyst Justin Post said in his note to clients that Google's outlook on profit margins will be key amid rising investments in cloud computing and other areas. In the December quarter, operating margins for the Google cloud computing business came in much lower than analyst estimates.</p>\n<p>\"Alphabet warned on increasing investments and accelerating pace of hiring on the last call, which took some of the luster away from revenue/margin beat,\" Post said. \"We expect quarter-over-quarter expense growth to be in focus.\"</p>\n<p>Amid coronavirus pandemic lockdowns, the drop-off in global travel impacted Google's advertising revenue. Google's core internet search business is expected to continue rebounding if economies reopen.</p>\n<p>Goggle Earnings: Digital Ad Business Rebounding</p>\n<p>Given this year's run-up in Google stock, investors need to see upside from other parts of its business, Credit Suisse analyst Stephen Ju said in a note.</p>\n<p>\"That the ad sector is in an across-all-verticals full recovery at this point is well understood,\" he wrote. \"We find ourselves asking what's next for Google as we look beyond what we anticipate will be better-than-expected advertiser spend across all of its properties. Our focus returns to YouTube.\"</p>\n<p>According to&nbsp;IBD MarketSmithanalysis, GOOGL stock forged a flat base with an entry point of 2,145.24. A5% buy zoneextends to 2,250. Google stock trades just above the buy zone.</p>\n<p>Heading into the Google earnings report, itsRelative Strength Rating&nbsp;is 78 out of a best possible 99, according to&nbsp;IBD Stock Checkup.</p>\n<p><i>Follow Reinhardt Krause on Twitter@reinhardtk_techfor updates on 5G wireless, artificial intelligence, cybersecurity and cloud computing.</i></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Google Stock Momentum Will Be Tested In First Quarter Earnings Report</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoogle Stock Momentum Will Be Tested In First Quarter Earnings Report\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/608dd68a89ed486e18f64efe3136266c);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Investors </p>\n<p class=\"h-time\">2021-04-27 14:48</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares in Google-parent<b>Alphabet</b>(GOOGL) have been on a roll since it reported December-quarter earnings. But it may be hard for Google stock to deliver an encore performance with first-quarter results.</p>\n<p>\"We think Google faces a higher bar this quarter than the past few as expectations for a strong search and brand advertising recovery are anticipated,\" BMO Capital Markets analyst Daniel Salmon said in a report to clients.</p>\n<p>Google stock rose 0.4% to close at 2,309.93 on thestock market today.</p>\n<p>Google stock has advanced nearly 20% since it reported fourth-quarter earnings on Feb. 2. Google earnings for the first quarter are due after the market close on Tuesday.</p>\n<p>For the March quarter, analysts estimate adjusted profit of $15.66 per share, up 58% from $9.87 per share a year earlier. Google gross revenue, excluding traffic acquisition costs, will grow 25% to $51.53 billion, analysts estimate.</p>\n<p>Net revenue will come in at $42.36 billion, according to views. In the Google earnings report, analysts estimate EBITDA — earnings before interest, taxes, depreciation and amortization — of $18.84 billion.</p>\n<p>Google Stock: Rising Cloud Computing Investments</p>\n<p>At Bank of America, analyst Justin Post said in his note to clients that Google's outlook on profit margins will be key amid rising investments in cloud computing and other areas. In the December quarter, operating margins for the Google cloud computing business came in much lower than analyst estimates.</p>\n<p>\"Alphabet warned on increasing investments and accelerating pace of hiring on the last call, which took some of the luster away from revenue/margin beat,\" Post said. \"We expect quarter-over-quarter expense growth to be in focus.\"</p>\n<p>Amid coronavirus pandemic lockdowns, the drop-off in global travel impacted Google's advertising revenue. Google's core internet search business is expected to continue rebounding if economies reopen.</p>\n<p>Goggle Earnings: Digital Ad Business Rebounding</p>\n<p>Given this year's run-up in Google stock, investors need to see upside from other parts of its business, Credit Suisse analyst Stephen Ju said in a note.</p>\n<p>\"That the ad sector is in an across-all-verticals full recovery at this point is well understood,\" he wrote. \"We find ourselves asking what's next for Google as we look beyond what we anticipate will be better-than-expected advertiser spend across all of its properties. Our focus returns to YouTube.\"</p>\n<p>According to&nbsp;IBD MarketSmithanalysis, GOOGL stock forged a flat base with an entry point of 2,145.24. A5% buy zoneextends to 2,250. Google stock trades just above the buy zone.</p>\n<p>Heading into the Google earnings report, itsRelative Strength Rating&nbsp;is 78 out of a best possible 99, according to&nbsp;IBD Stock Checkup.</p>\n<p><i>Follow Reinhardt Krause on Twitter@reinhardtk_techfor updates on 5G wireless, artificial intelligence, cybersecurity and cloud computing.</i></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GOOG":"谷歌","GOOGL":"谷歌A"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1123330430","content_text":"Shares in Google-parentAlphabet(GOOGL) have been on a roll since it reported December-quarter earnings. But it may be hard for Google stock to deliver an encore performance with first-quarter results.\n\"We think Google faces a higher bar this quarter than the past few as expectations for a strong search and brand advertising recovery are anticipated,\" BMO Capital Markets analyst Daniel Salmon said in a report to clients.\nGoogle stock rose 0.4% to close at 2,309.93 on thestock market today.\nGoogle stock has advanced nearly 20% since it reported fourth-quarter earnings on Feb. 2. Google earnings for the first quarter are due after the market close on Tuesday.\nFor the March quarter, analysts estimate adjusted profit of $15.66 per share, up 58% from $9.87 per share a year earlier. Google gross revenue, excluding traffic acquisition costs, will grow 25% to $51.53 billion, analysts estimate.\nNet revenue will come in at $42.36 billion, according to views. In the Google earnings report, analysts estimate EBITDA — earnings before interest, taxes, depreciation and amortization — of $18.84 billion.\nGoogle Stock: Rising Cloud Computing Investments\nAt Bank of America, analyst Justin Post said in his note to clients that Google's outlook on profit margins will be key amid rising investments in cloud computing and other areas. In the December quarter, operating margins for the Google cloud computing business came in much lower than analyst estimates.\n\"Alphabet warned on increasing investments and accelerating pace of hiring on the last call, which took some of the luster away from revenue/margin beat,\" Post said. \"We expect quarter-over-quarter expense growth to be in focus.\"\nAmid coronavirus pandemic lockdowns, the drop-off in global travel impacted Google's advertising revenue. Google's core internet search business is expected to continue rebounding if economies reopen.\nGoggle Earnings: Digital Ad Business Rebounding\nGiven this year's run-up in Google stock, investors need to see upside from other parts of its business, Credit Suisse analyst Stephen Ju said in a note.\n\"That the ad sector is in an across-all-verticals full recovery at this point is well understood,\" he wrote. \"We find ourselves asking what's next for Google as we look beyond what we anticipate will be better-than-expected advertiser spend across all of its properties. Our focus returns to YouTube.\"\nAccording to IBD MarketSmithanalysis, GOOGL stock forged a flat base with an entry point of 2,145.24. A5% buy zoneextends to 2,250. Google stock trades just above the buy zone.\nHeading into the Google earnings report, itsRelative Strength Rating is 78 out of a best possible 99, according to IBD Stock Checkup.\nFollow Reinhardt Krause on Twitter@reinhardtk_techfor updates on 5G wireless, artificial intelligence, cybersecurity and cloud computing.","news_type":1},"isVote":1,"tweetType":1,"viewCount":358,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":377167829,"gmtCreate":1619507223461,"gmtModify":1704725093711,"author":{"id":"3569246059375185","authorId":"3569246059375185","name":"Terry_Tey","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569246059375185","authorIdStr":"3569246059375185"},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/377167829","repostId":"1123330430","repostType":4,"isVote":1,"tweetType":1,"viewCount":313,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":348861891,"gmtCreate":1617916639513,"gmtModify":1704704700166,"author":{"id":"3569246059375185","authorId":"3569246059375185","name":"Terry_Tey","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569246059375185","authorIdStr":"3569246059375185"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LKCO\">$Luokung Technology Corp(LKCO)$</a>.....","listText":"<a href=\"https://laohu8.com/S/LKCO\">$Luokung Technology Corp(LKCO)$</a>.....","text":"$Luokung Technology Corp(LKCO)$.....","images":[{"img":"https://static.tigerbbs.com/7928ada698c721d5fdb4a48ca299c2c7","width":"528","height":"1024"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/348861891","isVote":1,"tweetType":1,"viewCount":588,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":357961373,"gmtCreate":1617233062592,"gmtModify":1704697506676,"author":{"id":"3569246059375185","authorId":"3569246059375185","name":"Terry_Tey","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569246059375185","authorIdStr":"3569246059375185"},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/357961373","repostId":"2123765862","repostType":4,"repost":{"id":"2123765862","pubTimestamp":1617203869,"share":"https://ttm.financial/m/news/2123765862?lang=&edition=fundamental","pubTime":"2021-03-31 23:17","market":"sg","language":"en","title":"UOB CEO's pay falls 8.8% to $9.8m in 2020","url":"https://stock-news.laohu8.com/highlight/detail?id=2123765862","media":"The Straits Times","summary":"SINGAPORE (THE BUSINESS TIMES) - UOB chief executive officer Wee Ee Cheong earned a total salary of ","content":"<div>\n<p>SINGAPORE (THE BUSINESS TIMES) - UOB chief executive officer Wee Ee Cheong earned a total salary of S$9.805 million in 2020, down 8.8 per cent from S$10.75 million in 2019, according to the bank's ...</p>\n\n<a href=\"http://www.straitstimes.com/business/banking/uob-ceos-pay-falls-88-to-98m-in-2020\">Web Link</a>\n\n</div>\n","source":"straits_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UOB CEO's pay falls 8.8% to $9.8m in 2020</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUOB CEO's pay falls 8.8% to $9.8m in 2020\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-31 23:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://www.straitstimes.com/business/banking/uob-ceos-pay-falls-88-to-98m-in-2020><strong>The Straits Times</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SINGAPORE (THE BUSINESS TIMES) - UOB chief executive officer Wee Ee Cheong earned a total salary of S$9.805 million in 2020, down 8.8 per cent from S$10.75 million in 2019, according to the bank's ...</p>\n\n<a href=\"http://www.straitstimes.com/business/banking/uob-ceos-pay-falls-88-to-98m-in-2020\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"U11.SI":"大华银行"},"source_url":"http://www.straitstimes.com/business/banking/uob-ceos-pay-falls-88-to-98m-in-2020","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2123765862","content_text":"SINGAPORE (THE BUSINESS TIMES) - UOB chief executive officer Wee Ee Cheong earned a total salary of S$9.805 million in 2020, down 8.8 per cent from S$10.75 million in 2019, according to the bank's annual report out on Wednesday.\nMr Wee's base salary remained unchanged at S$1.2 million. He received an S$8.568 million in bonuses, and S$37,000 in benefits-in-kind and others.\nAs before, 60 per cent of the variable pay due to Mr Wee will be deferred and vest over three years.\nOf the deferred portion, 40 per cent will be in cash, and the remaining 60 per cent will be in the form of share-linked units.\nIn his message in the annual report, Mr Wee noted the banks' commitment to deepening its Asean franchise; enhancing digital capabilities so customers can transform their businesses; and investing in developing its people's capabilities.\nUOB shares closed down S$0.10 or 0.39 per cent at S$25.83 on Wednesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":425,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":898291468,"gmtCreate":1628498436454,"gmtModify":1703507100917,"author":{"id":"3569246059375185","authorId":"3569246059375185","name":"Terry_Tey","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569246059375185","authorIdStr":"3569246059375185"},"themes":[],"htmlText":"…..","listText":"…..","text":"…..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/898291468","repostId":"1190142555","repostType":4,"repost":{"id":"1190142555","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1628497921,"share":"https://ttm.financial/m/news/1190142555?lang=&edition=fundamental","pubTime":"2021-08-09 16:32","market":"us","language":"en","title":"Microvast shares surged nearly 9% in premarket trading.","url":"https://stock-news.laohu8.com/highlight/detail?id=1190142555","media":"Tiger Newspress","summary":"Heading into a new trading week,Microvast Holdings Inc.,AMC Entertainment Holdings Inc. and Clover Health Investments Corp. are among the stocks seeing the highest interest on Reddit’s r/WallStreetBets forum, as of Sunday night.Microvast’s shares rose more than 11% on Friday, extending gains to a third straight day amid high interest from retail investors after posters on the WSB forum were criticalof Morgan Stanley analyst Adam Jones’ bearish price target on the stock. A post on the WSB forum h","content":"<p>Microvast&nbsp;shares&nbsp;surged&nbsp;nearly&nbsp;9%&nbsp;in premarket&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/7f6978d9fc57cfaca436942717528ae3\" tg-width=\"1290\" tg-height=\"622\" referrerpolicy=\"no-referrer\">Heading into a new trading week,<b>Microvast Holdings Inc.</b>,<b>AMC Entertainment Holdings Inc.</b>&nbsp;and&nbsp;<b>Clover Health Investments Corp.</b>&nbsp;are among the stocks seeing the highest interest on Reddit’s r/WallStreetBets forum, as of Sunday night.</p>\n<p>Microvast’s shares rose more than 11% on Friday, extending gains to a third straight day amid high interest from retail investors after posters on the WSB forum&nbsp;were criticalof Morgan Stanley analyst Adam Jones’ bearish price target on the stock. A&nbsp;post&nbsp;on the WSB forum has dubbed Microvast a “hidden gem.”</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Microvast shares surged nearly 9% in premarket trading.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicrovast shares surged nearly 9% in premarket trading.\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-08-09 16:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Microvast&nbsp;shares&nbsp;surged&nbsp;nearly&nbsp;9%&nbsp;in premarket&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/7f6978d9fc57cfaca436942717528ae3\" tg-width=\"1290\" tg-height=\"622\" referrerpolicy=\"no-referrer\">Heading into a new trading week,<b>Microvast Holdings Inc.</b>,<b>AMC Entertainment Holdings Inc.</b>&nbsp;and&nbsp;<b>Clover Health Investments Corp.</b>&nbsp;are among the stocks seeing the highest interest on Reddit’s r/WallStreetBets forum, as of Sunday night.</p>\n<p>Microvast’s shares rose more than 11% on Friday, extending gains to a third straight day amid high interest from retail investors after posters on the WSB forum&nbsp;were criticalof Morgan Stanley analyst Adam Jones’ bearish price target on the stock. A&nbsp;post&nbsp;on the WSB forum has dubbed Microvast a “hidden gem.”</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CLOV":"Clover Health Corp","AMC":"AMC院线","MVST":"Microvast Holdings, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190142555","content_text":"Microvast shares surged nearly 9% in premarket trading.\nHeading into a new trading week,Microvast Holdings Inc.,AMC Entertainment Holdings Inc. and Clover Health Investments Corp. are among the stocks seeing the highest interest on Reddit’s r/WallStreetBets forum, as of Sunday night.\nMicrovast’s shares rose more than 11% on Friday, extending gains to a third straight day amid high interest from retail investors after posters on the WSB forum were criticalof Morgan Stanley analyst Adam Jones’ bearish price target on the stock. A post on the WSB forum has dubbed Microvast a “hidden gem.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":344,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":140729786,"gmtCreate":1625674755045,"gmtModify":1703746289855,"author":{"id":"3569246059375185","authorId":"3569246059375185","name":"Terry_Tey","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569246059375185","authorIdStr":"3569246059375185"},"themes":[],"htmlText":"o","listText":"o","text":"o","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/140729786","repostId":"1133802649","repostType":4,"isVote":1,"tweetType":1,"viewCount":151,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9000155100,"gmtCreate":1640046821090,"gmtModify":1676533499180,"author":{"id":"3569246059375185","authorId":"3569246059375185","name":"Terry_Tey","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569246059375185","authorIdStr":"3569246059375185"},"themes":[],"htmlText":"huhuhuh","listText":"huhuhuh","text":"huhuhuh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9000155100","repostId":"1102941409","repostType":4,"repost":{"id":"1102941409","pubTimestamp":1640044036,"share":"https://ttm.financial/m/news/1102941409?lang=&edition=fundamental","pubTime":"2021-12-21 07:47","market":"us","language":"en","title":"After-Hours Stock Movers: Micron,Nike,Aldeyra Therapeutics and more","url":"https://stock-news.laohu8.com/highlight/detail?id=1102941409","media":"StreetInsider","summary":"Micron Technology +6.6%; reported Q1 EPS of $2.16, $0.05 better than the analyst estimate of $2.11. Revenue for the quarter came in at $7.69 billion versus the consensus estimate of $7.67 billion. GUIDANCE: Micron Technology sees Q2 2022 EPS of $1.85-$2.05, versus the consensus of $1.86. Micron Technology sees Q2 2022 revenue of $7.3-7.7 billion, versus the consensus of $7.27 billion.Nike +3.4%; reported Q2 EPS of $0.83, $0.20 better than the analyst estimate of $0.63. Revenue for the quarter ca","content":"<p>After-Hours Stock Movers:</p>\n<p>Micron Technology (NASDAQ:MU)<b>+6.6%</b>; reported Q1 EPS of $2.16, $0.05 better than the analyst estimate of $2.11. Revenue for the quarter came in at $7.69 billion versus the consensus estimate of $7.67 billion. GUIDANCE: Micron Technology sees Q2 2022 EPS of $1.85-$2.05, versus the consensus of $1.86. Micron Technology sees Q2 2022 revenue of $7.3-7.7 billion, versus the consensus of $7.27 billion.</p>\n<p>Nike (NYSE:NKE)<b>+3.4%</b>; reported Q2 EPS of $0.83, $0.20 better than the analyst estimate of $0.63. Revenue for the quarter came in at $11.4 billion versus the consensus estimate of $11.25 billion.</p>\n<p>Aldeyra Therapeutics (NASDAQ:ALDX)<b>-39%</b>; announced top-line results from the Phase 3 TRANQUILITY Trial of 0.25% reproxalap ophthalmic solution (reproxalap), an investigational product candidate for the treatment of dry eye disease. Although the primary endpoint of ocular redness was not met in TRANQUILITY, statistical significance (p=0.0001) was achieved for the dry eye disease sign of Schirmer test, a secondary endpoint. Statistical significance (p&lt;0.0001) was also achieved for the post-hoc assessment of Schirmer test responders of ≥10 mm.</p>\n<p>Society Pass (NASDAQ: SOPA)<b>-11.8%</b>; Climbed 240% intraday.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Micron,Nike,Aldeyra Therapeutics and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Micron,Nike,Aldeyra Therapeutics and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-21 07:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1220%3A+%28MU%29+%28NKE%29+%28ALDX%29+%28SOPA%29/19375559.html><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nMicron Technology (NASDAQ:MU)+6.6%; reported Q1 EPS of $2.16, $0.05 better than the analyst estimate of $2.11. Revenue for the quarter came in at $7.69 billion versus the ...</p>\n\n<a href=\"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1220%3A+%28MU%29+%28NKE%29+%28ALDX%29+%28SOPA%29/19375559.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NKE":"耐克","ALDX":"Aldeyra Therapeutics Inc","SOPA":"Society Pass Inc","MU":"美光科技"},"source_url":"https://www.streetinsider.com/Special+Reports/After-Hours+Stock+Movers+1220%3A+%28MU%29+%28NKE%29+%28ALDX%29+%28SOPA%29/19375559.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102941409","content_text":"After-Hours Stock Movers:\nMicron Technology (NASDAQ:MU)+6.6%; reported Q1 EPS of $2.16, $0.05 better than the analyst estimate of $2.11. Revenue for the quarter came in at $7.69 billion versus the consensus estimate of $7.67 billion. GUIDANCE: Micron Technology sees Q2 2022 EPS of $1.85-$2.05, versus the consensus of $1.86. Micron Technology sees Q2 2022 revenue of $7.3-7.7 billion, versus the consensus of $7.27 billion.\nNike (NYSE:NKE)+3.4%; reported Q2 EPS of $0.83, $0.20 better than the analyst estimate of $0.63. Revenue for the quarter came in at $11.4 billion versus the consensus estimate of $11.25 billion.\nAldeyra Therapeutics (NASDAQ:ALDX)-39%; announced top-line results from the Phase 3 TRANQUILITY Trial of 0.25% reproxalap ophthalmic solution (reproxalap), an investigational product candidate for the treatment of dry eye disease. Although the primary endpoint of ocular redness was not met in TRANQUILITY, statistical significance (p=0.0001) was achieved for the dry eye disease sign of Schirmer test, a secondary endpoint. Statistical significance (p<0.0001) was also achieved for the post-hoc assessment of Schirmer test responders of ≥10 mm.\nSociety Pass (NASDAQ: SOPA)-11.8%; Climbed 240% intraday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":549,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":140720450,"gmtCreate":1625674685370,"gmtModify":1703746287881,"author":{"id":"3569246059375185","authorId":"3569246059375185","name":"Terry_Tey","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569246059375185","authorIdStr":"3569246059375185"},"themes":[],"htmlText":"???","listText":"???","text":"???","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/140720450","repostId":"1128740137","repostType":4,"isVote":1,"tweetType":1,"viewCount":459,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":348861891,"gmtCreate":1617916639513,"gmtModify":1704704700166,"author":{"id":"3569246059375185","authorId":"3569246059375185","name":"Terry_Tey","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569246059375185","authorIdStr":"3569246059375185"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LKCO\">$Luokung Technology Corp(LKCO)$</a>.....","listText":"<a href=\"https://laohu8.com/S/LKCO\">$Luokung Technology Corp(LKCO)$</a>.....","text":"$Luokung Technology Corp(LKCO)$.....","images":[{"img":"https://static.tigerbbs.com/7928ada698c721d5fdb4a48ca299c2c7","width":"528","height":"1024"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/348861891","isVote":1,"tweetType":1,"viewCount":588,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":357961373,"gmtCreate":1617233062592,"gmtModify":1704697506676,"author":{"id":"3569246059375185","authorId":"3569246059375185","name":"Terry_Tey","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569246059375185","authorIdStr":"3569246059375185"},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/357961373","repostId":"2123765862","repostType":4,"isVote":1,"tweetType":1,"viewCount":425,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":377120005,"gmtCreate":1619507252007,"gmtModify":1704725094365,"author":{"id":"3569246059375185","authorId":"3569246059375185","name":"Terry_Tey","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569246059375185","authorIdStr":"3569246059375185"},"themes":[],"htmlText":"....","listText":"....","text":"....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/377120005","repostId":"1123330430","repostType":4,"isVote":1,"tweetType":1,"viewCount":358,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":377167829,"gmtCreate":1619507223461,"gmtModify":1704725093711,"author":{"id":"3569246059375185","authorId":"3569246059375185","name":"Terry_Tey","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":5,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3569246059375185","authorIdStr":"3569246059375185"},"themes":[],"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/377167829","repostId":"1123330430","repostType":4,"isVote":1,"tweetType":1,"viewCount":313,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}